Trevi Therapeutics, Inc.
TRVI
$7.55
$0.060.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 203.89M | 103.26M | 107.62M | 65.49M | 69.50M |
| Total Receivables | 834.00K | 460.00K | 532.00K | 285.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.77M | 1.53M | 939.00K | 1.18M | 1.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 743.00K | 374.00K | 335.00K | 382.00K | 830.00K |
| Total Current Assets | 207.23M | 105.62M | 109.43M | 67.34M | 72.13M |
|
|
|||||
| Total Current Assets | 207.23M | 105.62M | 109.43M | 67.34M | 72.13M |
| Net Property, Plant & Equipment | 1.04M | 1.14M | 1.23M | 1.32M | 1.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 68.00K | 241.00K | 243.00K | 256.00K | 273.00K |
| Total Assets | 208.34M | 107.00M | 110.90M | 68.91M | 73.81M |
|
|
|||||
| Total Accounts Payable | 2.97M | 1.42M | 3.41M | 1.61M | 1.51M |
| Total Accrued Expenses | 5.98M | 5.17M | 6.81M | 7.21M | 4.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 286.00K | 276.00K | 285.00K | 297.00K | 309.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.24M | 6.87M | 10.51M | 9.12M | 6.75M |
|
|
|||||
| Total Current Liabilities | 9.24M | 6.87M | 10.51M | 9.12M | 6.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 605.00K | 681.00K | 747.00K | 816.00K | 884.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.85M | 7.55M | 11.26M | 9.94M | 7.64M |
|
|
|||||
| Common Stock & APIC | 508.16M | 396.77M | 386.63M | 334.46M | 328.65M |
| Retained Earnings | -309.69M | -297.39M | -287.05M | -275.63M | -262.39M |
| Treasury Stock & Other | 24.00K | 73.00K | 61.00K | 139.00K | -84.00K |
| Total Common Equity | 198.49M | 99.46M | 99.64M | 58.97M | 66.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 198.49M | 99.46M | 99.64M | 58.97M | 66.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 198.49M | 99.46M | 99.64M | 58.97M | 66.17M |
|
|
|||||